Lars Michel
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
- PARP inhibition in cancer therapy
Papers in
- Oncology 22
- Cancer Immunotherapy and Biomarkers 13
- Cancer Treatment and Pharmacology 4
- Peptidase Inhibition and Analysis 4
-
- Chemotherapy-induced cardiotoxicity and mitigation 11
- Cardiovascular Function and Risk Factors 4
- Co-authors
- Tienush Rassaf (39 shared papers)Matthias Totzeck (28 shared papers)Raluca Mincu (11 shared papers)Amir A. Mahabadi (14 shared papers)Fadi Al‐Rashid (4 shared papers)Simone M. Mrotzek (8 shared papers)Stephan Settelmeier (5 shared papers)Dirk Schadendorf (6 shared papers)
- Journals
- European Heart Journal (10 papers)Current Heart Failure Reports (4 papers)ESC Heart Failure (4 papers)Experimental Hematology (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- GermanyHungaryUnited States
In The Last Decade
Lars Michel
42 papers receiving 889 citations
Peers
Comparison fields: 5 of 76
- Cardiology and Cardiovascular Medicine 434
- Oncology 330
- Radiology, Nuclear Medicine and Imaging 117
- Biophysics 23
- Pulmonary and Respiratory Medicine 99
Countries citing papers authored by Lars Michel
This map shows the geographic impact of Lars Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Michel more than expected).
Fields of papers citing papers by Lars Michel
This network shows the impact of papers produced by Lars Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Michel. The network helps show where Lars Michel may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Michel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 170 | |
| 2 | 2019 | 115 | |
| 3 | 2019 | 87 | |
| 4 | 2010 | 84 | |
| 5 | 2022 | 67 | |
| 6 | 2018 | 66 | |
| 7 | 2019 | 55 | |
| 8 | 2020 | 30 | |
| 9 | 2013 | 28 | |
| 10 | 2020 | 21 | |
| 11 | 2023 | 15 | |
| 12 | 2019 | 15 | |
| 13 | 2020 | 13 | |
| 14 | 2020 | 13 | |
| 15 | 2024 | 12 | |
| 16 | 2024 | 12 | |
| 17 | 2016 | 12 | |
| 18 | 2022 | 10 | |
| 19 | 2020 | 10 | |
| 20 | 2020 | 9 |
About Lars Michel
Lars Michel is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Molecular Biology, Pulmonary and Respiratory Medicine and Electrical and Electronic Engineering, having authored 49 papers that have together received 901 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Chemotherapy-induced cardiotoxicity and mitigation (11 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Advancements in Semiconductor Devices and Circuit Design (7 papers), Cancer Treatment and Pharmacology (4 papers), Peptidase Inhibition and Analysis (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Cardiac Imaging and Diagnostics (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (434 citations), Oncology (330 citations), Radiology, Nuclear Medicine and Imaging (117 citations), Biophysics (23 citations) and Pulmonary and Respiratory Medicine (99 citations). Lars Michel has collaborated with scholars based in Germany, Hungary and United States. Frequent co-authors include Tienush Rassaf, Matthias Totzeck, Raluca Mincu, Amir A. Mahabadi, Fadi Al‐Rashid, Simone M. Mrotzek, Stephan Settelmeier, Dirk Schadendorf, Yi Lin and Joerg Herrmann. Their work appears in journals such as European Heart Journal, Current Heart Failure Reports, ESC Heart Failure, Experimental Hematology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.